Company:  MUSCLEPHARM CORP (MSLP)
Form Type:  10-K
Filing Date:  3/31/2014 
CIK:  0001415684 
Address:  4721 IRONTON STREET 
City, State, Zip:  DENVER, Colorado 80239 
Telephone:  (800) 210-7369 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.76  
Change: 
0.26 (5.78%)  
Trade Time: 
03:28 PM EST  
Market Cap: 
$65.24M
Trade MSLP now with 

Description of Business
MusclePharm Corporation is a scientifically driven, performance lifestyle company that develops, manufactures, markets and distributes branded nutritional supplements through a broad range of powders, capsules, tablets and gels. Our portfolio of recognized brands, including MusclePharm® Hybrid and Core Series, Arnold Schwarzenegger Series(TM), and FitMiss® are marketed and sold in more than 110 countries and available in over 35,000 retail outlets globally. These clinically developed, scientifically driven nutritional supplements are developed through a six-stage research process that utilizes the expertise of leading nutritional scientists, doctors and universities. MusclePharm is a growth company with a portfolio of brands that we believe fuels this growth across all nutritional supplement categories and geographies. We had net revenue of $177.4 million in 2014, representing an annual growth rate of 60%, and a 2-year compound annual growth rate of 63%.
Register and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business
      Item 1A. Risk Factors
      Item 1B. Unresolved Staff Comments
      Item 2. Properties
      Item 3. Legal Proceedings
      Item 4. Mine Safety Disclosures
    PART II
      Item 5. Market for Registrant's Common Equity, Related ...
      Item 6. Selected Financial Data.
      Item 7. Management's Discussion and Analysis of Financial ...
        Results of Operations
        Liquidity and Capital Resources
      Item 8. Consolidated Financial Statements and Supplementary Data
        Report of Independent Registered Public Accounting Firm
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        Notes to Consolidated Financial Statements
          Note 17: Subsequent Events
      Item 9. Changes in and Disagreements with Accountants on ...
      Item 9A. Controls and Procedures
      Item 9B. Other Information
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance
        NAME AND TITLE
      Item 11. Executive Compensation
        COMPENSATION TABLE
        OPTIONS AGGREGATE
        NAME AND TITLE
      Item 12. Security Ownership of Certain Beneficial Owners and ...
        BENEFICIAL OWNERS
        BENEFICIAL OWNERS
      Item 13. Certain Relationships, Related Transactions and ...
      Item 14. Principal Accountant Fees and Services
    PART IV
      Item 15. Exhibits, Financial Statement Schedules
    Signatures
    EXHIBIT INDEX
  EXHIBIT 10.37
  EXHIBIT 10.38
  EXHIBIT 21
    SUBSIDIARIES
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    Section 1350 CERTIFICATION
  EXHIBIT 32.2
    Section 1350 CERTIFICATION